Tamoxifen Citrate

ACTIVE HALF-LIFE 5-7 Days
CLASSIFICATION SERM
DOSAGE 20 mg/day
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Hilma Biocare
LAB TEST See Document
WAREHOUSE EU Warehouse 3
SUBSTANCE Tamoxifen Citrate

Discover the power of Tamoxifen Citrate, a versatile medication renowned for its pharmacological prowess. Acting as both an estrogen antagonist and agonist in various tissues, this compound was developed in 1961 by ICI (AstraZeneca) and has become a cornerstone in breast cancer treatment. Beyond its primary use, Tamoxifen Citrate effectively tackles estrogen-related side effects from anabolic steroid use, making it a must-have for athletes and bodybuilders during post-cycle therapy (PCT).

Not only is it effective for breast cancer, but Tamoxifen Citrate also shows promise in treating other cancers like ovarian, endometrial, prostate, and kidney cancers, as well as conditions such as melanoma and soft tissue sarcomas, particularly when tumors express estrogen receptors. As a member of the Selective Estrogen Receptor Modulator (SERM) class, it plays a pivotal role in restoring testosterone levels and rejuvenating libido in athletes after steroid cycles.

Effects:
While Tamoxifen Citrate is celebrated for its benefits, some users may experience mild side effects, including headaches, insomnia, nausea, digestive discomfort, fatigue, and leg cramps.

Stacking:
For enhanced results during PCT, Tamoxifen Citrate can be effectively stacked with clomiphene.